HB384
Log in to followAN ACT relating to intranasal epinephrine.
Amend KRS 158.832 to include intranasal epinephrine to list of medications used to treat anaphylaxis; amend KRS 158.836 to include intranasal epinephrine as permissible for schools to keep.
Introduced: February 6, 2025
Last action: February 12, 2025
Plain-language summary
This bill would update Kentucky school health law to add intranasal epinephrine, a medication delivered through the nose, to the list of approved treatments for severe allergic reactions. It would also allow schools to keep intranasal epinephrine on hand alongside other anaphylaxis medications they are already permitted to stock. Who it may affect: students and school staff, particularly those at risk for severe allergic reactions.
Open official bill text (PDF)·Report a problem with the summary
Legislative History
Primary Sponsor
Co-sponsors (1)
Bill Text Versions
Something wrong on this page? Tell us
